Clene Reports Third Quarter 2026 Financial Results and Recent Operating HighlightsGlobeNewsWire • 11/04/26
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALSGlobeNewsWire • 10/19/26
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDAGlobeNewsWire • 09/21/26
Clene Reports Second Quarter 2026 Financial Results and Recent Operating HighlightsGlobeNewsWire • 08/14/26
Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 06/04/26
Clene Reports First Quarter 2026 Financial Results and Recent Operating HighlightsGlobeNewsWire • 05/14/26
Clene Reports Full Year 2025 Financial Results and Recent Operating HighlightsGlobeNewsWire • 03/12/26
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 CatalystsGlobeNewsWire • 02/24/26
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA MeetingGlobeNewsWire • 01/12/26